2 ms·
I guess you are wondering why this is better than Ivermectin. From the article: > The MOVe-OUT trial (MK-4482-002) (NCT04575597) was a global Phase 3, randomiz
by gus_massa 5y ago
I guess you are wondering why this is better than Ivermectin. From the article:
> The MOVe-OUT trial (MK-4482-002) (NCT04575597) was a global Phase 3, randomized, placebo-controlled, double-blind, multi-site study [...]
If you go to https://ivmmeta.com/ https://ivmmeta.com/ you will see:
* Most of the studies have not placebo, they just compare a group of people with another unrelated group of people. It's very difficult to be sure there are no unexpected differences.
* If you filter only the RCT, most of them are not statistically significant. That is a problem because if the drug has no effect, the reporting/publishing/selection bias will cause barely significant studies to accumulate.
* There are only 6 that RCT that are statistically significant. Have you read them? Some have very weird things that are very big red flags.
If Ivermectin has no effect, I expect like 2 of the RCT that are statistically significant to be caused by flukes. Can you pick your favorite 3?